Annual Net Income
-$20.55 M
-$1.46 M-7.67%
December 31, 2023
Summary
- As of February 8, 2025, ONCY annual net profit is -$20.55 million, with the most recent change of -$1.46 million (-7.67%) on December 31, 2023.
- During the last 3 years, ONCY annual net income has fallen by -$3.76 million (-22.36%).
- ONCY annual net income is now -5215.00% below its all-time high of -$386.70 thousand, reached on December 31, 1999.
Performance
ONCY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$6.99 M
-$1.69 M-31.91%
September 30, 2024
Summary
- As of February 8, 2025, ONCY quarterly net profit is -$6.99 million, with the most recent change of -$1.69 million (-31.91%) on September 30, 2024.
- Over the past year, ONCY quarterly net income has increased by +$402.50 thousand (+5.44%).
- ONCY quarterly net income is now -2445.86% below its all-time high of $298.10 thousand, reached on March 31, 2020.
Performance
ONCY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$20.31 M
+$402.50 K+1.94%
September 30, 2024
Summary
- As of February 8, 2025, ONCY TTM net profit is -$20.31 million, with the most recent change of +$402.50 thousand (+1.94%) on September 30, 2024.
- Over the past year, ONCY TTM net income has increased by +$3.68 million (+15.33%).
- ONCY TTM net income is now -10835.27% below its all-time high of -$185.70 thousand, reached on March 31, 2000.
Performance
ONCY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ONCY Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.7% | +5.4% | +15.3% |
| 3 y3 years | -22.4% | -11.0% | -6.8% |
| 5 y5 years | -56.3% | -11.0% | -6.8% |
ONCY Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.7% | +2.0% | -141.1% | +5.4% | -10.3% | +15.3% |
| 5 y | 5-year | -22.4% | +17.6% | -2445.9% | +52.4% | -20.5% | +18.8% |
| alltime | all time | -5215.0% | +43.5% | -2445.9% | +52.4% | <-9999.0% | +48.2% |
Oncolytics Biotech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.99 M(+31.9%) | -$20.31 M(-1.9%) |
| Jun 2024 | - | -$5.30 M(+3.7%) | -$20.71 M(-1.1%) |
| Mar 2024 | - | -$5.11 M(+76.2%) | -$20.94 M(+1.7%) |
| Dec 2023 | -$20.55 M(+7.7%) | -$2.90 M(-60.8%) | -$20.59 M(-14.2%) |
| Sep 2023 | - | -$7.40 M(+33.7%) | -$23.98 M(+20.1%) |
| Jun 2023 | - | -$5.53 M(+16.3%) | -$19.96 M(+8.4%) |
| Mar 2023 | - | -$4.76 M(-24.5%) | -$18.42 M(-3.1%) |
| Dec 2022 | -$19.09 M(-9.0%) | -$6.30 M(+86.6%) | -$19.01 M(+0.8%) |
| Sep 2022 | - | -$3.38 M(-15.3%) | -$18.86 M(-2.5%) |
| Jun 2022 | - | -$3.99 M(-25.5%) | -$19.35 M(-9.0%) |
| Mar 2022 | - | -$5.35 M(-13.0%) | -$21.27 M(+1.3%) |
| Dec 2021 | -$20.98 M(+24.9%) | -$6.15 M(+59.0%) | -$20.99 M(-4.6%) |
| Sep 2021 | - | -$3.87 M(-34.4%) | -$22.00 M(-5.2%) |
| Jun 2021 | - | -$5.90 M(+16.2%) | -$23.20 M(+4.4%) |
| Mar 2021 | - | -$5.08 M(-29.1%) | -$22.22 M(+31.9%) |
| Dec 2020 | -$16.80 M(-32.7%) | -$7.16 M(+41.4%) | -$16.85 M(-30.9%) |
| Sep 2020 | - | -$5.06 M(+2.8%) | -$24.39 M(+10.9%) |
| Jun 2020 | - | -$4.93 M(-1752.2%) | -$21.99 M(+4.8%) |
| Mar 2020 | - | $298.10 K(-102.0%) | -$21.00 M(-16.0%) |
| Dec 2019 | -$24.96 M(+89.8%) | -$14.70 M(+450.2%) | -$25.01 M(+79.2%) |
| Sep 2019 | - | -$2.67 M(-32.0%) | -$13.95 M(+0.9%) |
| Jun 2019 | - | -$3.93 M(+5.7%) | -$13.84 M(+5.0%) |
| Mar 2019 | - | -$3.71 M(+1.9%) | -$13.17 M(+0.1%) |
| Dec 2018 | -$13.15 M(+9.1%) | -$3.64 M(+42.8%) | -$13.16 M(-0.7%) |
| Sep 2018 | - | -$2.55 M(-21.8%) | -$13.24 M(+1.2%) |
| Jun 2018 | - | -$3.26 M(-11.8%) | -$13.09 M(+0.2%) |
| Mar 2018 | - | -$3.70 M(-0.9%) | -$13.06 M(+8.7%) |
| Dec 2017 | -$12.05 M(+5.4%) | -$3.73 M(+55.7%) | -$12.02 M(-1.4%) |
| Sep 2017 | - | -$2.40 M(-25.9%) | -$12.19 M(-1.3%) |
| Jun 2017 | - | -$3.23 M(+21.7%) | -$12.35 M(+11.1%) |
| Mar 2017 | - | -$2.66 M(-32.0%) | -$11.12 M(-2.4%) |
| Dec 2016 | -$11.43 M(+6.3%) | -$3.90 M(+52.8%) | -$11.39 M(+12.7%) |
| Sep 2016 | - | -$2.56 M(+27.6%) | -$10.10 M(+4.1%) |
| Jun 2016 | - | -$2.00 M(-31.6%) | -$9.71 M(-10.4%) |
| Mar 2016 | - | -$2.93 M(+11.8%) | -$10.83 M(+0.5%) |
| Dec 2015 | -$10.75 M(-36.2%) | -$2.62 M(+21.3%) | -$10.78 M(-6.1%) |
| Sep 2015 | - | -$2.16 M(-31.1%) | -$11.48 M(-15.5%) |
| Jun 2015 | - | -$3.13 M(+9.2%) | -$13.58 M(-8.1%) |
| Mar 2015 | - | -$2.87 M(-13.7%) | -$14.78 M(-12.5%) |
| Dec 2014 | -$16.87 M(-26.2%) | -$3.32 M(-21.9%) | -$16.88 M(-11.5%) |
| Sep 2014 | - | -$4.26 M(-1.5%) | -$19.08 M(-7.9%) |
| Jun 2014 | - | -$4.32 M(-13.1%) | -$20.70 M(-2.7%) |
| Mar 2014 | - | -$4.98 M(-9.8%) | -$21.29 M(-6.9%) |
| Dec 2013 | -$22.85 M(-37.2%) | -$5.52 M(-6.2%) | -$22.87 M(-11.8%) |
| Sep 2013 | - | -$5.89 M(+20.0%) | -$25.91 M(-11.6%) |
| Jun 2013 | - | -$4.91 M(-25.2%) | -$29.31 M(-15.0%) |
| Mar 2013 | - | -$6.56 M(-23.4%) | -$34.48 M(-5.2%) |
| Dec 2012 | -$36.38 M | -$8.56 M(-7.7%) | -$36.37 M(-7.2%) |
| Sep 2012 | - | -$9.28 M(-7.9%) | -$39.21 M(+8.0%) |
| Jun 2012 | - | -$10.08 M(+19.4%) | -$36.29 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$8.44 M(-26.0%) | -$33.62 M(+15.1%) |
| Dec 2011 | -$29.37 M(+22.9%) | -$11.41 M(+79.2%) | -$29.20 M(+7.0%) |
| Sep 2011 | - | -$6.36 M(-14.0%) | -$27.28 M(+0.3%) |
| Jun 2011 | - | -$7.40 M(+83.8%) | -$27.19 M(+14.9%) |
| Mar 2011 | - | -$4.03 M(-57.6%) | -$23.66 M(-1.4%) |
| Dec 2010 | -$23.91 M(+67.3%) | -$9.49 M(+51.2%) | -$24.00 M(+23.2%) |
| Sep 2010 | - | -$6.28 M(+62.1%) | -$19.47 M(+24.4%) |
| Jun 2010 | - | -$3.87 M(-11.2%) | -$15.65 M(+1.0%) |
| Mar 2010 | - | -$4.36 M(-12.1%) | -$15.50 M(+8.2%) |
| Dec 2009 | -$14.29 M(-13.5%) | -$4.96 M(+102.1%) | -$14.33 M(+7.8%) |
| Sep 2009 | - | -$2.46 M(-34.1%) | -$13.29 M(-10.3%) |
| Jun 2009 | - | -$3.72 M(+16.9%) | -$14.81 M(-9.1%) |
| Mar 2009 | - | -$3.18 M(-18.8%) | -$16.29 M(-0.7%) |
| Dec 2008 | -$16.53 M(+13.0%) | -$3.92 M(-1.4%) | -$16.41 M(+0.2%) |
| Sep 2008 | - | -$3.98 M(-23.6%) | -$16.37 M(+2.2%) |
| Jun 2008 | - | -$5.20 M(+57.3%) | -$16.02 M(+11.9%) |
| Mar 2008 | - | -$3.31 M(-15.0%) | -$14.31 M(-1.4%) |
| Dec 2007 | -$14.63 M(+16.1%) | -$3.89 M(+7.3%) | -$14.52 M(-2.7%) |
| Sep 2007 | - | -$3.62 M(+3.6%) | -$14.92 M(+4.0%) |
| Jun 2007 | - | -$3.50 M(-0.4%) | -$14.35 M(+6.2%) |
| Mar 2007 | - | -$3.51 M(-18.2%) | -$13.52 M(+7.3%) |
| Dec 2006 | -$12.60 M(+19.4%) | -$4.29 M(+40.5%) | -$12.60 M(+8.0%) |
| Sep 2006 | - | -$3.05 M(+14.7%) | -$11.67 M(+1.2%) |
| Jun 2006 | - | -$2.66 M(+2.7%) | -$11.53 M(+2.6%) |
| Mar 2006 | - | -$2.59 M(-22.8%) | -$11.24 M(+6.2%) |
| Dec 2005 | -$10.55 M(+5.8%) | -$3.36 M(+15.0%) | -$10.59 M(+23.2%) |
| Sep 2005 | - | -$2.92 M(+23.0%) | -$8.60 M(-0.8%) |
| Jun 2005 | - | -$2.37 M(+22.4%) | -$8.66 M(+0.3%) |
| Mar 2005 | - | -$1.94 M(+42.2%) | -$8.63 M(-1.0%) |
| Dec 2004 | -$9.97 M(+63.2%) | -$1.36 M(-54.3%) | -$8.73 M(+0.9%) |
| Sep 2004 | - | -$2.98 M(+27.1%) | -$8.65 M(+23.8%) |
| Jun 2004 | - | -$2.35 M(+15.6%) | -$6.99 M(-6.1%) |
| Mar 2004 | - | -$2.03 M(+57.5%) | -$7.44 M(+21.0%) |
| Dec 2003 | -$6.11 M(+57.5%) | -$1.29 M(-2.3%) | -$6.14 M(+5.2%) |
| Sep 2003 | - | -$1.32 M(-52.9%) | -$5.84 M(+0.8%) |
| Jun 2003 | - | -$2.80 M(+279.3%) | -$5.79 M(+51.5%) |
| Mar 2003 | - | -$737.70 K(-25.0%) | -$3.82 M(-1.6%) |
| Dec 2002 | -$3.88 M(-2.6%) | -$983.10 K(-22.8%) | -$3.88 M(+3.3%) |
| Sep 2002 | - | -$1.27 M(+53.9%) | -$3.76 M(-7.6%) |
| Jun 2002 | - | -$827.60 K(+3.6%) | -$4.07 M(-1.3%) |
| Mar 2002 | - | -$798.80 K(-6.8%) | -$4.12 M(+3.4%) |
| Dec 2001 | -$3.99 M(+63.8%) | -$857.30 K(-45.9%) | -$3.99 M(+15.1%) |
| Sep 2001 | - | -$1.58 M(+80.0%) | -$3.46 M(+18.2%) |
| Jun 2001 | - | -$879.80 K(+32.5%) | -$2.93 M(+0.7%) |
| Mar 2001 | - | -$664.20 K(+98.2%) | -$2.91 M(+19.7%) |
| Dec 2000 | -$2.43 M(+529.3%) | -$335.20 K(-68.1%) | -$2.43 M(+16.0%) |
| Sep 2000 | - | -$1.05 M(+22.2%) | -$2.10 M(+100.5%) |
| Jun 2000 | - | -$860.40 K(+363.3%) | -$1.05 M(+463.3%) |
| Mar 2000 | - | -$185.70 K | -$185.70 K |
| Dec 1999 | -$386.70 K | - | - |
FAQ
- What is Oncolytics Biotech annual net profit?
- What is the all time high annual net income for Oncolytics Biotech?
- What is Oncolytics Biotech annual net income year-on-year change?
- What is Oncolytics Biotech quarterly net profit?
- What is the all time high quarterly net income for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly net income year-on-year change?
- What is Oncolytics Biotech TTM net profit?
- What is the all time high TTM net income for Oncolytics Biotech?
- What is Oncolytics Biotech TTM net income year-on-year change?
What is Oncolytics Biotech annual net profit?
The current annual net income of ONCY is -$20.55 M
What is the all time high annual net income for Oncolytics Biotech?
Oncolytics Biotech all-time high annual net profit is -$386.70 K
What is Oncolytics Biotech annual net income year-on-year change?
Over the past year, ONCY annual net profit has changed by -$1.46 M (-7.67%)
What is Oncolytics Biotech quarterly net profit?
The current quarterly net income of ONCY is -$6.99 M
What is the all time high quarterly net income for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly net profit is $298.10 K
What is Oncolytics Biotech quarterly net income year-on-year change?
Over the past year, ONCY quarterly net profit has changed by +$402.50 K (+5.44%)
What is Oncolytics Biotech TTM net profit?
The current TTM net income of ONCY is -$20.31 M
What is the all time high TTM net income for Oncolytics Biotech?
Oncolytics Biotech all-time high TTM net profit is -$185.70 K
What is Oncolytics Biotech TTM net income year-on-year change?
Over the past year, ONCY TTM net profit has changed by +$3.68 M (+15.33%)